Derivative exercise or conversion — not an open-market buy.
Traded Nov 17, 2025 · Filed Nov 19, 2025
C.H. Robinson's Chief Strat & Innov Officer sold $382K of C.H. Robinson shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$381,925
Shares × reported transaction price
19 days after results of Oct 29, 2025, 72 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $152.64 on Nov 17, 2025, within 2% of its 52-week high, after a 14% rise over the previous 30 trading days
52-week range $86.965 (Apr 8, 2025) to $154.88 (Oct 30, 2025), 97% of the way up, from 250 adjusted closes. 30 trading days earlier: $134.36 on Oct 6, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.4% | +2.6% | +2.8% |
| 30 days | +10.0% | +2.7% | +7.3% |
| 90 days | +17.2% | +3.0% | +14.1% |
| 180 days | +12.1% | +11.5% | +0.7% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.